Design Therapeutics, Inc. (DSGN) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -70.80M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-70.80M | (m) |
| 2026-03-31 | (m) | $-69.71M | (m) |
| 2025-12-31 | (m) | $-69.79M | (m) |
| 2025-09-30 | (m) | $-67.45M | (m) |
| 2025-06-30 | (m) | $-63.49M | (m) |
| 2025-03-31 | (m) | $-56.20M | (m) |
| 2024-12-31 | (m) | $-49.59M | (m) |
| 2024-09-30 | (m) | $-47.78M | (m) |
| 2024-06-30 | (m) | $-50.53M | (m) |
| 2024-03-31 | (m) | $-58.67M | (m) |
| 2023-12-31 | (m) | $-66.86M | (m) |
| 2023-09-30 | (m) | $-72.36M | (m) |
| 2023-06-30 | (m) | $-74.28M | (m) |
| 2023-03-31 | (m) | $-69.34M | (m) |
| 2022-12-31 | (m) | $-63.31M | (m) |
| 2022-09-30 | (m) | $-57.03M | (m) |
| 2022-06-30 | (m) | $-50.65M | (m) |
| 2022-03-31 | (m) | $-43.28M | (m) |
| 2021-12-31 | (m) | $-35.53M | (m) |
| 2021-09-30 | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) |
| 2020-12-31 | (m) | $-8.28M | (m) |
| 2020-09-30 | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |